Roth Still Bullish on Ligand Pharma (LGND) Following NOXAFIL Approval (MRK)
Go back to Roth Still Bullish on Ligand Pharma (LGND) Following NOXAFIL Approval (MRK)| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 280.49 -4.03 (1.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $284.52 | 52 Week High | $139.79 | |||
| Open | $283.70 | 52 Week Low | $82.07 | |||
| Day High | $284.00 | P/E | 652.30 | |||
| Day Low | $277.36 | EPS | $0.43 | |||
| Volume | 127,696 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 148.35 -1.19 (0.8%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $149.54 | 52 Week High | $65.46 | |||
| Open | $146.72 | 52 Week Low | $47.97 | |||
| Day High | $149.01 | P/E | 100.92 | |||
| Day Low | $145.75 | EPS | $1.47 | |||
| Volume | 8,067,765 | |||||

